What Siris Pharmaceutical Services does

Siris Pharmaceutical Services is a privately held for-profit company that provides pharmaceutical manufacturing services, per its firmographic record. It was founded in 2001 and is headquartered in Bloomsbury, United States. The firm operates at a small scale, with headcount reported in the 11-50 employee range, consistent with a specialist contract development and manufacturing organization (CDMO) or niche service provider rather than a large-scale commercial manufacturer.

The company's website (sirispharma.com) could not be retrieved during data collection, as the page rendered only a verification/loading message. Consequently, no specific information is available regarding Siris's service mix (e.g., API synthesis, solid oral dose manufacturing, sterile fill-finish, analytical services), the regulatory certifications it holds (e.g., FDA registration, cGMP, DEA registration), its customer segments, or its go-to-market motion. No management team, funding history, partnerships, awards, patents, product launches, or corporate actions are disclosed in the available data.

Given the absence of detailed disclosures, the business model, pricing structure, customer concentration, and revenue mechanics cannot be characterized beyond the high-level statement that the firm sells pharmaceutical manufacturing services to external clients. Investment diligence should prioritize direct outreach to obtain a services catalog, quality certifications list, customer roster, and audited financials before drawing further conclusions about unit economics or competitive positioning.

Name

Siris Pharmaceutical Services

Website

https://sirispharma.com

Company type

Private

Founded year

2001

Headcount range

11–50 employees

Short description

Siris Pharmaceutical Services is a privately held U.S.-based pharmaceutical contract manufacturing firm founded in 2001 and headquartered in Bloomsbury, employing 11-50 staff to provide pharmaceutical manufacturing services to external clients.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industries

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

Keywords

• Pharmaceutical manufacturing services
• Contract pharmaceutical manufacturing
• Drug product manufacturing
• Pharmaceutical contract services
• Small molecule manufacturing

Headquarters

HQ city

Bloomsbury

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure

Core offering

Siris Pharmaceutical Services provides pharmaceutical manufacturing services to external clients. As a contract manufacturer, the company produces drug products on behalf of pharmaceutical sponsors, brand owners, or other organizations requiring third-party manufacturing capacity. Specific service scope, dosage forms, and capabilities are not detailed in the available source material.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Catalent: Global CDMO offering a full range of pharmaceutical development, manufacturing, and packaging services across dosage forms. Comparable to Siris as a contract pharma manufacturer, but operating at vastly larger scale and serving big-pharma sponsors globally.
• Patheon (Thermo Fisher Scientific): Integrated pharmaceutical contract development and manufacturing organization under Thermo Fisher. Overlaps directly with Siris's pharmaceutical manufacturing services positioning but with much broader capabilities and scale.
• Piramal Pharma Solutions: Global CDMO providing integrated drug substance and drug product services including sterile fill-finish and oral solids. Comparable in pharmaceutical manufacturing services but with substantially broader capabilities.
• WuXi AppTec / WuXi STA: One of the largest global CDMOs offering end-to-end pharmaceutical development and manufacturing services. Comparable service scope to Siris but operating at industrial scale across Asia, US, and Europe.
• Aurobindo Pharma: Vertically integrated generic pharmaceutical manufacturer with significant contract manufacturing capabilities. Overlaps with Siris in pharmaceutical manufacturing services, particularly for generic and off-patent molecules.

Direct peers

• Cambrex: Specialty CDMO focused on small-molecule API and finished dosage form development and manufacturing. Highly comparable to Siris in service offering and target customer base of small-to-mid pharma companies.
• Hovione: Independent CDMO specializing in API development, particle engineering, and drug product manufacturing. Closely comparable to Siris as a focused pharmaceutical manufacturing services provider with similar customer profile.
• AMRI (Curia): CDMO offering contract research, API manufacturing, and finished dosage form services. Comparable to Siris across the pharmaceutical manufacturing services value chain, particularly for small-molecule programs.
• Almac Group: Privately held CDMO providing pharmaceutical development, manufacturing, and clinical trial supply services. Comparable to Siris as an independent pharmaceutical manufacturing services firm with similar customer mix.
• Seqens: Integrated pharmaceutical CDMO offering API synthesis, custom manufacturing, and finished dosage forms. Comparable in scope and customer profile, particularly for specialty and small-molecule manufacturing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Siris Pharmaceutical Services